Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 4
2022 pubmed

25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics.

Aldekwer. Sahar S; Goncalves-Mendes. Nicolas N; Bingula. Rea R; Martinroche. Guillaume G; Lanchais. Kassandra K; Rougé. Stéphanie S; Farges. Marie-Chantal MC; Rossary. Adrien A; Diab-Assaf. Mona M; Vasson. Marie-Paule MP; Talvas. Jérémie J

Key Findings

  • 25‑OH‑vitamin D dose‑dependently increases CAMP gene expression in PBMCs, up to 100‑fold when cells are stimulated with LPS
  • Intracellular hCAP18 protein rises modestly (1.5‑2.5‑fold) with high vitamin D doses
  • Extracellular LL‑37 secretion only rises with vitamin D when cells are stimulated by bacterial (LPS) or viral (Poly I:C) mimetics

Practical Outcomes

  • Maintain vitamin D levels in the high‑normal to slightly supraphysiological range, especially during periods of infection or immune stress, to potentially enhance LL‑37 release. Simply supplementing vitamin D won’t raise circulating LL‑37 unless the immune system is activated, so timing with exposure to pathogens or immune challenges matters. Monitor blood 25‑OH‑D to avoid excessive dosing.

Summary

Taking enough vitamin D (aiming for blood levels around 75‑125 ng/mL) can boost the cells that make the antimicrobial peptide LL‑37, but the peptide only gets released outside the cells when the immune system is activated by something like a bacterial or viral trigger. In plain terms, higher vitamin D may help your body’s natural antibiotics kick in faster during an infection, but it won’t raise baseline LL‑37 levels on its own.

Abstract

Human cathelicidin refers to the cationic antimicrobial peptide hCAP18/LL-37. LL-37 is formed by cleavage of the propeptide hCAP18 coded by the CAMP gene. The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)D), has been shown to induce the CAMP gene expression through promoter activation. We previously failed to demonstrate in a clinical trial that supplementation of 25-hydroxyvitamin D (25(OH)D) improves LL-37 serum levels. The aim of this work was to evaluate the impact of 25(OH)D supplementation on intracellular expression of CAMP and secretion of LL-37 in an ex vivo model using the peripheral blood mononuclear cells (PBMC). PBMC collected from healthy donors and incubated with different concentrations of 25(OH)D (0 ng/ml: control (D0); 25 ng/ml: deficient (D25); 75 ng/ml: physiological (D75); 125 ng/ml: supraphysiological (D125)) were stimulated or not with lipopolysaccharide (LPS, 100 ng/ml) or synthetic double-stranded RNA Poly (I: C) (PIC, 10 µg/ml). The intracellular expressions of the CAMP gene and the hCAP18 peptide were measured respectively after 24-h and 48-h incubation periods. The concentration of LL-37 was determined in the culture medium after 48-h incubation. 25(OH)D significantly induced CAMP gene expression at 24 h with a maximum effect at a dose of D125 in either unstimulated (tenfold expression) or stimulated (LPS: 100-fold expression; PIC: 15-fold expression) conditions. Intracellular hCAP18 peptide was overexpressed at 48 h under unstimulated (1.5-fold, D125) and stimulated conditions, LPS (twofold, D125) and PIC (2.5-fold, D125). The secretion of LL-37 in the culture medium was significantly induced by 25(OH)D only in both stimulated (LPS and PIC) conditions in a dose-dependent manner. Our results demonstrate that 25(OH)D incubation increases intracellular expression of CAMP and hCAP18, but extracellular secretion of LL-37 antimicrobial peptide is increased by 25(OH)D only when PBMC from healthy donors were stimulated with bacterial or viral immune mimetic.

Study Information

Provider

pubmed

Year

2022

Date

2022-01-05T00:00:00.000Z

DOI

10.1007/s13105-021-00868-z